Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre of Medical Genetics, |
RCV000663606 | SCV002025567 | likely pathogenic | Marfan syndrome | 2021-03-01 | criteria provided, single submitter | research | PM2, PS6, PP4 |
Invitae | RCV001861730 | SCV002296885 | uncertain significance | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2021-01-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FBN1 protein function. This variant has not been reported in the literature in individuals with FBN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 549134). This variant is not present in population databases (ExAC no frequency). This sequence change replaces phenylalanine with serine at codon 1051 of the FBN1 protein (p.Phe1051Ser). The phenylalanine residue is highly conserved and there is a large physicochemical difference between phenylalanine and serine. |
Center for Medical Genetics Ghent, |
RCV000663606 | SCV000786926 | uncertain significance | Marfan syndrome | 2017-11-07 | no assertion criteria provided | clinical testing |